Butler S, O'Neill B
Physiotherapy Department, Victoria Hospital, London, Ontario, Canada.
Pediatr Pulmonol. 1995 Jan;19(1):56-9. doi: 10.1002/ppul.1950190109.
A new device, the ThAIRapy Bronchial Drainage System, enables patients with cystic fibrosis to self-administer the technique of high frequency chest compression (HFCC) to assist with mucociliary clearance. We review the literature on HFCC and outline a case study of a patient currently using the ThAIRapy Bronchial Drainage System. While mucociliary clearance and lung function may be enhanced by HFCC therapy, more research is needed to determine its efficacy, cost benefits, and optimum treatment guidelines. Although our initial experience with the patient using this device has been positive, we were unable to accurately evaluate the ThAIRapy Bronchial Drainage System.
一种新型设备——ThAIRapy支气管引流系统，使囊性纤维化患者能够自行实施高频胸部按压（HFCC）技术，以辅助黏液纤毛清除。我们回顾了关于HFCC的文献，并概述了一名目前正在使用ThAIRapy支气管引流系统的患者的案例研究。虽然HFCC疗法可能会增强黏液纤毛清除和肺功能，但仍需要更多研究来确定其疗效、成本效益和最佳治疗指南。尽管我们对使用该设备的患者的初步经验是积极的，但我们无法准确评估ThAIRapy支气管引流系统。
